Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy (Q43564797)

From Wikidata

Jump to navigation Jump to search

scientific article published in June 2004

Language	Label	Description	Also known as
English	Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy	scientific article published in June 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Cytomegalovirus

0 references

Vincent C Emery

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

author name string

Jane R Deayton

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Caroline A Prof Sabin

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Margaret A Johnson

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Pauline Wilson

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Paul D Griffiths

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

language of work or name

0 references

publication date

1 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

363

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

9427

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

2116-2121

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916500-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of cytomegalovirus (CMV) disease may be predicted in HIV-infected patients by CMV polymerase chain reaction and the antigenemia test

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916500-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Utility of urine and leukocyte cultures and plasma DNA polymerase chain reaction for identification of AIDS patients at risk for developing human cytomegalovirus disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916500-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916500-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus (CMV) infection, CD4+ lymphocyte counts and the development of AIDS in HIV-1-infected haemophiliac patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916500-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of CMV infection on progression of human immunodeficiency virus disease is a cohort of haemophilic men followed for up to 13 years from seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916500-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus seropositivity and human immunodeficiency virus type 1 RNA levels in individuals with hemophilia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916500-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunodeficiency virus-1 disease progression in hemophiliacs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916500-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus infection and risk of AIDS in human immunodeficiency virus-infected hemophilia patients. National Cancer Institute Multicenter Hemophilia Cohort Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916500-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Determinants of progression of HIV infection in a Greek hemophilia cohort followed for up to 16 years after seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916500-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistent cytomegalovirus infection of semen increases risk of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916500-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus retinitis in AIDS patients: influence of cytomegaloviral load on response to ganciclovir, time to recurrence and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916500-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916500-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus (CMV) DNA load is an independent predictor of CMV disease and survival in advanced AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916500-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916500-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Decline in deaths from AIDS due to new antiretrovirals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916500-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916500-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916500-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Provision of prognostic information in immunocompromised patients by routine application of the polymerase chain reaction for cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916500-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies of viral co-factors for human immunodeficiency virus in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916500-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Value of necropsy in acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916500-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinico-pathological audit of opportunistic viral infections in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916500-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Is cytomegalovirus infection a co-factor in HIV-1 disease progression?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916500-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916500-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916500-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916500-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(04)16500-8

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43564797&oldid=2101128598"